Clinical Trials · NCT07065552
Tirzepatide in Obesity-Driven Endometrial Cancer
- Phase
- EARLY_Phase 1
- Recruitment status
- Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Enrollment
- 20
- Start date
- Apr 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in Proliferation